Identification of a molecular profile that may predict early relapse in patients undergoing multimodality therapy in muscle-invasive bladder cancer (MIBC). Diverse long-time progression-free survival ...
Liver cancer is one of the most prevalent cancers worldwide, with an estimated number of more than 900,000 new cases per year. Among these cases, hepatocellular carcinoma (HCC) accounts for more than ...
Golgi protein 73 (GP73) and alpha fetoprotein (AFP) serve as biomarkers for the diagnosis of hepatocellular carcinoma (HCC), and their serum levels correlate with patients’ outcomes. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results